Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by mutations in the survival motor neuron 1 (<i>SMN2</i>) gene. All patients have at least one copy of a paralog, <i>SMN2</i>, but a C-to-T transition in this gene results in exon 7 skipping in a majority of tra...
Main Authors: | Winkelsas, AM, Grunseich, C, Harmison, GG, Chwalenia, K, Rinaldi, C, Hammond, SM, Johnson, K, Bowerman, M, Arya, S, Talbot, K, Wood, MJ, Fischbeck, KH |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Cell Press
2021
|
Similar Items
-
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Winkelsas, AM
Published: (2020) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017) -
Spinal muscular atrophy.
by: Talbot, K, et al.
Published: (2001) -
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
by: Wood, M, et al.
Published: (2017)